ODT - Odonate Therapeutics - Stock Forecast

Pharmaceuticals - Sector

Healthcare - Industry

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $12.3. This is a potential upside of $12.3 (0%) from yesterday's end of day stock price of $0.

Odonate Therapeutics's activity chart (see below) currently has 0 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 90% with an average time for these price targets to be met of 161 days.

Most recent stock forecast was given by PAUL CHOI from GOLDMAN on 22-Mar-2021. First documented stock forecast 23-Oct-2018.

Best performing analysts who are covering ODT - Odonate Therapeutics:

Paul Choi Michael Yee

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

$4

$2.71 (210.08%)

$11

4 years 7 months 4 days ago
(22-Mar-2021)

4/5 (80%)

$0.04 (1.01%)

41

Buy

$40

$38.71 (3000.78%)

7 years 3 days ago
(23-Oct-2018)

1/1 (100%)

$24.56 (159.07%)

281

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ODT (Odonate Therapeutics) average time for price targets to be met?

On average it took 161 days on average for the stock forecasts to be realized with a an average price target met ratio 90

Which analyst has the current highest performing score on ODT (Odonate Therapeutics) with a proven track record?

PAUL CHOI

Which analyst has the current lower performing score on ODT (Odonate Therapeutics) with a proven track record?

MICHAEL YEE

Which analyst has the most public recommendations on ODT (Odonate Therapeutics)?

Paul Choi works at GOLDMAN SACHS and has 6 price targets and 5 ratings on ODT

Which analyst is the currently most bullish on ODT (Odonate Therapeutics)?

Michael Yee with highest potential upside - $38.71

Which analyst is the currently most reserved on ODT (Odonate Therapeutics)?

Paul Choi with lowest potential downside - $2.71

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?